Experienced in Urea Cycle Disorders (UCD)

Xiaotang Cai

Key Laboratory Of Obstetric And Gynecologic And Pediatric Diseases And Birth Defects Of Ministry Of Education, 
Chengdu, CN 
Experienced in Urea Cycle Disorders (UCD)
Key Laboratory Of Obstetric And Gynecologic And Pediatric Diseases And Birth Defects Of Ministry Of Education, 
Chengdu, CN 
OverviewLocationsClinical Research

Overview

Xiaotang Cai practices in Chengdu, China. Cai is rated as an Experienced expert by MediFind in the treatment of Urea Cycle Disorders (UCD). Their top areas of expertise are Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Brain Abscess, Arginase Deficiency, and Hormone Replacement Therapy (HRT).

Their clinical research consists of co-authoring 24 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Urea Cycle Disorders (UCD).

Locations

Key Laboratory Of Obstetric And Gynecologic And Pediatric Diseases And Birth Defects Of Ministry Of Education, Chengdu, China
Other Locations
West China Second University Hospital Key Laboratory Of Obstetric And Gynaecologic And Pediatric Diseases And Birth Defects Of Ministry Of Education, Peking Union Medical College Hospital, Beijing, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
A Phase 3, Randomized, Double-Blind, Trial of Pamrevlumab (FG-3019) or Placebo in Combination With Systemic Corticosteroids in Ambulatory Subjects With Duchenne Muscular Dystrophy (DMD)
Enrollment Status: Terminated
Publish Date: August 26, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3

24 Total Publications

Multi-Parametric Quantitative MRI in the Early Differential Diagnosis of Ambulatory Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
Multi-Parametric Quantitative MRI in the Early Differential Diagnosis of Ambulatory Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.
Journal: Journal of magnetic resonance imaging : JMRI
Published: November 29, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Cai's expertise for a condition
ConditionClose
      View All 19 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile